These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8737729)

  • 1. Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment.
    Gulko PS; Mulloy AL
    Clin Exp Rheumatol; 1996; 14(2):199-206. PubMed ID: 8737729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.
    Devogelaer JP; Goemaere S; Boonen S; Body JJ; Kaufman JM; Reginster JY; Rozenberg S; Boutsen Y
    Osteoporos Int; 2006 Jan; 17(1):8-19. PubMed ID: 16217586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucocorticoids and osteoporosis].
    Zikán V
    Vnitr Lek; 2007; 53(7-8):831-40. PubMed ID: 17915428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.
    Popp AW; Isenegger J; Buergi EM; Buergi U; Lippuner K
    Eur Spine J; 2006 Jul; 15(7):1035-49. PubMed ID: 16474946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
    Buckley L; Guyatt G; Fink HA; Cannon M; Grossman J; Hansen KE; Humphrey MB; Lane NE; Magrey M; Miller M; Morrison L; Rao M; Byun Robinson A; Saha S; Wolver S; Bannuru RR; Vaysbrot E; Osani M; Turgunbaev M; Miller AS; McAlindon T
    Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1095-1110. PubMed ID: 28585410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucocorticoid-induced osteoporosis].
    Yasuda S; Kogawa M; Wada S
    Nihon Rinsho; 2003 Feb; 61(2):280-6. PubMed ID: 12638222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Doga M; Mazziotti G; Bonadonna S; Patelli I; Bilezikian JP; Canalis E; Giustina A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):53-8. PubMed ID: 18791353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glucocorticoid-induced osteoporosis: review and proposition for prevention and treatment guidelines].
    Grazio S; Korsić M; Anić B; Vitezić-Misjak M; Grubisić F
    Lijec Vjesn; 2005; 127(1-2):36-43. PubMed ID: 16145872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-induced osteoporosis: prevention and treatment.
    Ziegler R; Kasperk C
    Steroids; 1998; 63(5-6):344-8. PubMed ID: 9618799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucocorticoid induced osteoporosis].
    Anić B; Mayer M
    Reumatizam; 2014; 61(2):105-12. PubMed ID: 25427404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced osteoporosis: pathogenesis and management.
    Nishimura J; Ikuyama S
    J Bone Miner Metab; 2000; 18(6):350-2. PubMed ID: 11052469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.
    Goldstein MF; Fallon JJ; Harning R
    Chest; 1999 Dec; 116(6):1733-49. PubMed ID: 10593801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Particular features of steroid-induced osteoporosis].
    Hein GE
    Orthopade; 2007 Aug; 36(8):708, 710-3. PubMed ID: 17643225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylaxis of glucocorticoid-induced osteoporosis].
    Tanaka Y
    Clin Calcium; 2006 Nov; 16(11):1858-65. PubMed ID: 17079853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates and glucocorticoid-induced osteoporosis: cons.
    Lems WF; Saag K
    Endocrine; 2015 Aug; 49(3):628-34. PubMed ID: 26041376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Active vitamin D3 therapy for gulucocorticoid-induced osteoporosis].
    Nakayama H
    Clin Calcium; 2006 Jul; 16(7):1201-7. PubMed ID: 16816482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.